ABSTRACT

Clinical importance of the bisphosphonate-related osteonecrosis of the jaw (BRONJ) which is one of the serious side effects of bisphosphonates is increasing due to the widespread use of bisphosphonates in the treatment of osteoporosis. Since current treatment options for the BRONJ are limited, evaluation of the risk factors is very important in preventing the development of BRONJ and determining the appropriate medication in osteoporosis management. In the present case report, diagnosis, pathogenesis and risk factors of the BORNJ which is observed following bisphosphonate use were reviewed. (Turkish Journal of Osteoporosis 2014;20: 75-80)